Associations and attributable burden between risk factors and all-cause and cause-specific mortality at different ages in patients with hypertension (2024)

References

Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 Countries. Circulation. 2016;134:441–50.
Article PubMed PubMed Central Google Scholar
Asayama K, Stolarz-Skrzypek K, Yang WY, Hansen TW, Brguljan-Hitij J, Odili AN, et al. What did we learn from the international databases on ambulatory and home blood pressure in relation to cardiovascular outcome? Hypertens Res. 2023;46:934–49.
Article PubMed PubMed Central Google Scholar
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–60.
Article PubMed Google Scholar
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–44.
Article PubMed Google Scholar
Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398–404.
Article CAS PubMed Google Scholar
Wang JG, Zhang W, Li Y, Liu L. Hypertension in China: epidemiology and treatment initiatives. Nat Rev Cardiol. 2023;20:531–45.
Article PubMed Google Scholar
Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023;44:2066–77.
Article CAS PubMed Google Scholar
Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol. 2020;75:2921–30.
Article PubMed Google Scholar
Lacey B, Lewington S, Clarke R, Kong XL, Chen Y, Guo Y, et al. Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study. Lancet Glob Health. 2018;6:e641–e9.
See Also
Hypertension—A Global Neurological Problem NON COMMUNICABLE DISEASES Notes | Knowt Effets chroniques des peptides angiotensines II et IV dans le système nerveux central Pulmonary Embolism System Disorder Template
Article PubMed PubMed Central Google Scholar
Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
Article Google Scholar
Liu J, Zhao D, Liu J, Qi Y, Sun J, Wang W. Prevalence of diabetes mellitus in outpatients with essential hypertension in China: a cross-sectional study. BMJ Open. 2013;3:e003798.
Article PubMed PubMed Central Google Scholar
Song J, Sheng CS, Huang QF, Li LH, Ma CS, Guo XH, et al. Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry. J Hypertens. 2016;34:1648–53.
Article CAS PubMed PubMed Central Google Scholar
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.
Article PubMed Google Scholar
Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control. 2007;18:571–9.
Article CAS PubMed Google Scholar
Smith JR, Sharrett AR, Pike JR, Gottesman RF, Knopman DS, Lee M, et al. Dementia occurring over a 32-year follow-up attributable to hypertension observed at different ages: Implications for dementia prevention. Alzheimers Dement. 2023;19:3435–47.
Article PubMed Google Scholar
Lee A. Seamless health care for chronic diseases in a dual health care system: managed care and the role of family physicians. J Manag Med. 1998;12:398–405, 322.
Article CAS PubMed Google Scholar
Yu EYT, Wan EYF, Mak IL, Chao DVK, Ko WWK, Leung M, et al. Assessment of hypertension complications and health service use 5 years after implementation of a multicomponent intervention. JAMA Netw Open. 2023;6:e2315064.
Article PubMed PubMed Central Google Scholar
Wan EY, Fung CS, Yu EY, Fong DY, Chen JY, Lam CL. Association of visit-to-visit variability of systolic blood pressure with cardiovascular disease and mortality in primary care chinese patients with type 2 diabetes-A retrospective population-based cohort study. Diabetes Care. 2017;40:270–9.
Article CAS PubMed Google Scholar
Jin Q, Lau ESH, Luk AO, Tam CHT, Ozaki R, Lim CKP et al. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank. Diabetologia. 2024. https://doi.org/10.1007/s00125-024-06108-5.
Jin Q, Kuen Lam CL, Fai Wan EY. Association of eGFR slope with all-cause mortality, macrovascular and microvascular outcomes in people with type 2 diabetes and early-stage chronic kidney disease. Diabetes Res Clin Pract. 2023;205:110924.
Article CAS PubMed Google Scholar
Jin Q, Luk AO, Lau ESH, Tam CHT, Ozaki R, Lim CKP, et al. Nonalbuminuric diabetic kidney disease and risk of all-cause mortality and cardiovascular and kidney outcomes in type 2 diabetes: findings from the hong kong diabetes biobank. Am J Kidney Dis. 2022;80:196–206.e1.
Article CAS PubMed Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Article PubMed PubMed Central Google Scholar
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–57.
Article CAS PubMed Google Scholar
6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S83–96.
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81-90.
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–72.
Article CAS PubMed PubMed Central Google Scholar
Rubin DB. Multiple imputation for nonresponse in surveys. John Wiley & Sons; Hoboken, New Jersey; 2004.
Mahmoodi BK, Matsush*ta K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380:1649–61.
Article PubMed PubMed Central Google Scholar
Hallan SI, Matsush*ta K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012;308:2349–60.
Article CAS PubMed PubMed Central Google Scholar
van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J. 2012;33:2088–97.
Article PubMed PubMed Central Google Scholar
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2:634–47.
Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W. Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care. 2017;40:1703–9.
Article PubMed Google Scholar
Sugiyama D, Okamura T, Watanabe M, Higashiyama A, Okuda N, Nakamura Y, et al. Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study. J Atheroscler Thromb. 2015;22:95–107.
Article PubMed Google Scholar
Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang J-f, et al. Mortality attributable to smoking in China. N. Engl J Med. 2009;360:150–9.
Article CAS PubMed Google Scholar
Ghazi L, Oparil S, Calhoun DA, Lin CP, Dudenbostel T. Distinctive risk factors and phenotype of younger patients with resistant hypertension: age is relevant. Hypertension. 2017;69:827–35.
Article CAS PubMed Google Scholar
Aguilar D. Preventing Heart Failure in People With Hypertension: The Time Is Now. JACC Heart Fail. 2023;11:689–90.
Maeda D, Dotare T, Matsue Y, Teramoto K, Sunayama T, Tromp J, et al. Blood pressure in heart failure management and prevention. Hypertens Res 2023;46:817–33.
Article PubMed Google Scholar
Anker SD, Usman MS, Butler J SGLT2 inhibitors: from antihyperglycemic agents to all-around heart failure therapy. In. Vol 146. Am Heart Assoc2022, 299-302.
Kjeldsen SE, Stenehjem A, Os I, Van de Borne P, Burnier M, Narkiewicz K, et al. Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets. Blood Press. 2016;25:333–6.
Article PubMed Google Scholar
Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ. 1998;316:1780–4.
Article CAS PubMed PubMed Central Google Scholar
Daw J. Contribution of four comorbid conditions to racial/ethnic disparities in mortality risk. Am J Prevent Med. 2017;52:S95–S102.
Article Google Scholar
Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–49.
Article Google Scholar

Associations and attributable burden between risk factors and all-cause and cause-specific mortality at different ages in patients with hypertension (2024)

FAQs

What is the burden of disease attributable to risk factors? ›

The disease burden (for example deaths, years of life lost or years lived with disability) attributable to a risk factor is the disease burden that would not have occurred if people had not been exposed to the risk factor in the past.

View Details ›

What blood pressure is associated with all-cause mortality? ›

Treatment to lower BP reduced the risk for all-cause mortality if the baseline SBP ranged from 140 to 159 mm Hg (RR, 0.87; 95% CI, 0.75-1.00) or was 160 mm Hg or above (RR, 0.93; 95% CI, 0.87-1.00).

Read On ›

Is hypertension the leading risk factor for death? ›

Data from the Centers for Disease Control and Prevention suggests that in 2021, hypertension was a primary cause or contributing cause of nearly 700,000 deaths in the United States.

Learn More Now ›

Which is the greatest risk factor for all-cause mortality? ›

But a sedentary lifestyle, characterized by lots of sitting and physical inactivity, is one of the leading risk factors for all-cause mortality.

Learn More ›

What are attributable risk factors? ›

Attributable risk (AR) is the portion of disease rate attributable to the exposure factor in the epidemiologic context, the portion of correct diagnosis rate attributable to a positive predictive result (e.g., lab test) in the clinical context, or the portion of beneficial outcome rate attributable to a treatment.

Get More Info Here ›

What are the 5 risk factors that cause the most disease burden in 2018? ›

Over one-third of disease burden is potentially preventable

The risk factors contributing the most burden in 2018 were tobacco use (8.6%), overweight (including obesity) (8.4%), followed by dietary risks (5.4%), high blood pressure (5.1%), and alcohol use (4.5%).

Which BP is more life-threatening? ›

A hypertensive crisis is a sudden, severe increase in blood pressure. The blood pressure reading is 180/120 millimeters of mercury (mm Hg) or greater. A hypertensive crisis is a medical emergency. It can lead to a heart attack, stroke or other life-threatening health problems.

Learn More ›

What is a long term high blood pressure a major risk factor for? ›

Untreated, high blood pressure increases the risk of heart attack, stroke and other serious health problems.

Get More Info ›

What is an illness leading to blood pressure that is higher than normal? ›

Known causes of high blood pressure

Health conditions that can cause high blood pressure include: kidney disease. diabetes. long-term kidney infections.

What three diseases does hypertension significantly raise the risk for? ›

cardiovascular disease (heart disease or stroke) diabetes (high blood sugar) chronic kidney disease.

What is the most significant risk factor for hypertension? ›

Unhealthy diet

A diet that is too high in sodium and too low in potassium puts you at risk for high blood pressure. Eating too much sodium—an element in table salt—increases blood pressure. Most of the sodium we eat comes from processed and restaurant foods.

Keep Reading ›

Can high blood pressure cause sudden death? ›

High blood pressure, also called hypertension, can quietly damage the body for years before symptoms appear. Without treatment, high blood pressure can lead to disability, a poor quality of life, or even a deadly heart attack or stroke.

Read The Full Story ›

Which is the strongest predictor of all-cause mortality? ›

Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study.

What is the leading risk factor for all-cause mortality? ›

Exposure to tobacco use led to the highest number of attributable deaths in all years (see Figure 9.1). Exposure to high blood pressure, overweight (including obesity) and dietary risks were the next leading causes of attributable death. All risk factors included in the ABDS accounted for 49% of all deaths in 2018.

View Details ›

What is the number one risk factor for death? ›

Heart disease is the leading cause of death for both men and women. This is the case in the U.S. and worldwide. More than half of all people who die due to heart disease are men. Medical professionals use the term heart disease to describe several conditions.

Read On ›

How do you describe the burden of disease? ›

The term burden of disease generally describes the total, cumulative consequences of a defined disease or a range of harmful diseases with respect to disabilities in a community. These consequences include health, social aspects, and costs to society.

Get More Info Here ›

What are the main factors of the burden of disease from environmental hazards? ›

Factors include air pollution, water and sanitation, increasing heat waves and severe weather events, harmful exposure to chemicals and more.

Discover More ›

What is the burden of disease measured by? ›

The overall burden of disease is assessed using the disability-adjusted life year (DALY), a time-based measure that combines years of life lost due to premature mortality (YLLs) and years of life lost due to time lived in states of less than full health, or years of healthy life lost due to disability (YLDs).

What are the determinants of the burden of disease? ›

What is Burden Of Disease? Considers health, social, political, environmental and economic factors to determine the cost that disease and disability exert upon the individual and society.

Discover More Details ›